Loading...
PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
Immunotherapy with check-point inhibitors serves as a promising treatment strategy in patients with upper gastrointestinal (GI) tumors. Human epidermal growth factor receptor 2 (HER2) is the only identified therapeutic target in upper GI tumors, whose potential interaction with programmed death-liga...
Na minha lista:
| Udgivet i: | Pathol Oncol Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Netherlands
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7471145/ https://ncbi.nlm.nih.gov/pubmed/32372174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-020-00814-2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|